IRIDEX Corp (IRIX, Financial) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. IRIDEX Corp designs, manufactures, and markets laser equipment used in the ophthalmologic and aesthetic fields. IRIDEX Corp has a market cap of $61.990 million; its shares were traded at around $4.56 with and P/S ratio of 1.28.
For the last quarter IRIDEX Corp reported a revenue of $11.5 million, compared with the revenue of $10.24 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $42.6 million, an increase of 2.4% from last year. For the last five years IRIDEX Corp had an average revenue growth rate of 1.6% a year.
The reported loss per diluted share was $1.05 for the year. The IRIDEX Corp had an operating margin of -30.21%, compared with the operating margin of -31.32% a year before. The 10-year historical median operating margin of IRIDEX Corp is 1.34%. The profitability rank of the company is 5 (out of 10).
At the end of the fiscal year, IRIDEX Corp has the cash and cash equivalents of $21.2 million, compared with $21.7 million in the previous year. The company had no long term debt. IRIDEX Corp has a financial strength rank of 9 (out of 10).
At the current stock price of $4.56, IRIDEX Corp is traded at 15.1% discount to its historical median P/S valuation band of $5.37. The P/S ratio of the stock is 1.28, while the historical median P/S ratio is 1.52. The stock lost 23.32% during the past 12 months.
For the complete 20-year historical financial data of IRIX, click here.
